Loader
Latest News
HR3630: Lymphedema Treatment Act (117th Congress)
20411
wp-singular,page-template-default,page,page-id-20411,wp-theme-bridge,bridge-core-3.3.4.9,qode-optimizer-1.2.3,qode-page-transition-enabled,ajax_fade,page_not_loaded,,qode_grid_1400,side_menu_slide_from_right,qode-theme-ver-30.8.9.1,qode-theme-bridge,qode_header_in_grid,wpb-js-composer js-comp-ver-9.0.1,vc_responsive
 

HR3630: Lymphedema Treatment Act

117th Congress (2021–2023) · House bill · Sponsor: Rep. Schakowsky, Janice D. [D-IL-9]

This page covers HR3630 in the 117th Congress. Bill numbers start over every Congress, so HR3630 in another Congress is a different bill.


Key facts

Item Detail
Roll-call votes 1
Chamber House
Latest vote 2022-11-17: Passed
Latest action 2022-11-17: Received in the Senate and Read twice and referred to the Committee on Finance.
Policy area Health
Official record Congress.gov

What the bill does

Lymphedema Treatment Act This bill provides for Medicare coverage of lymphedema compression treatment items. Specifically, the bill provides for coverage of standard and custom fitted gradient compression garments and other approved items that are prescribed by a physician or other specified health care professional to treat lymphedema.

Subjects: Cardiovascular and respiratory health, Health care coverage and access, Immunology and vaccination, Medicare


Roll-call votes on HR3630 (117th Congress)

Every recorded vote on this bill, newest first, with a link to the official tally. Member-by-member positions are on each member’s profile.

Date Chamber Question Result Yea Nay Not voting Record
2022-11-17 House 2/3 Yea-And-Nay Passed 286 7 6 Official tally

Frequently asked

What is HR3630 in the 117th Congress?

HR3630 (Lymphedema Treatment Act) was introduced in the 117th Congress (2021–2023) by Rep. Schakowsky, Janice D. [D-IL-9].

What is the latest action on HR3630?

On 2022-11-17: Received in the Senate and Read twice and referred to the Committee on Finance.

How many roll-call votes were held on HR3630?

1 recorded vote in the 117th Congress. The most recent, on 2022-11-17, was "2/3 Yea-And-Nay": Passed.